
OTC · ELOX
Eloxx Pharmaceuticals, Inc.
Healthcare · Biotechnology
$20.98
Up+$2.94 (+16.27%)
Updated Aug 23, 2026, 9:05 PM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 314
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- $0.00 – $23.40
- Volume
- 93.39K
- Avg. volume
- 1.44K
Price performance
ELOX price history
1M range · 20 trading sessions · Daily adjusted prices
ELOX closed at $20.98 after 20 trading sessions, up 73.20% for the selected period.
- Last close
- $20.98
- Period change
- +73.20%
- Period low
- $12.11
- Period high
- $20.98
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $19.00 | $23.3999 | $18.04 | $20.975 | 93.39K |
| Aug 20, 2026 | $19.00 | $19.18 | $17.75 | $18.04 | 40.28K |
| Aug 19, 2026 | $17.56 | $19.00 | $16.90 | $18.155 | 62.74K |
| Aug 18, 2026 | $18.47 | $18.47 | $16.50 | $18.25 | 38.25K |
| Aug 17, 2026 | $18.87 | $18.90 | $17.735 | $18.47 | 27.93K |
| Aug 14, 2026 | $19.23 | $19.23 | $17.17 | $18.76 | 29.64K |
| Aug 13, 2026 | $18.15 | $19.19 | $17.8035 | $19.07 | 33.28K |
| Aug 12, 2026 | $19.82 | $19.855 | $17.2538 | $18.265 | 45.15K |
| Aug 11, 2026 | $18.39 | $19.96 | $17.98 | $19.18 | 51.27K |
| Aug 10, 2026 | $16.80 | $18.48 | $16.80 | $17.00 | 62.61K |
| Aug 7, 2026 | $17.88 | $18.3799 | $17.39 | $17.57 | 32.43K |
| Aug 6, 2026 | $17.4145 | $18.5883 | $16.50 | $17.71 | 20.53K |
| Aug 5, 2026 | $18.03 | $19.30 | $16.5379 | $17.88 | 58.57K |
| Aug 4, 2026 | $18.44 | $19.10 | $17.5001 | $18.43 | 44.61K |
| Aug 3, 2026 | $18.24 | $19.358 | $15.67 | $18.45 | 65.89K |
| Jul 31, 2026 | $13.90 | $18.4212 | $13.79 | $17.43 | 53.37K |
| Jul 30, 2026 | $12.41 | $13.7499 | $12.41 | $13.30 | 18.88K |
| Jul 29, 2026 | $13.36 | $14.00 | $12.01 | $12.24 | 53.67K |
| Jul 28, 2026 | $12.01 | $13.50 | $11.81 | $12.81 | 22.36K |
| Jul 27, 2026 | $11.79 | $12.11 | $10.975 | $12.11 | 238.63K |
Latest ELOX news
The latest Smart Investors Daily articles mentioning ELOX.

